Tesofensine and beta blocker combination formulations

The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of...

Full description

Saved in:
Bibliographic Details
Main Authors Højgaard, Bent, Thomsen, Mikael S, Nielsen, Peter G
Format Patent
LanguageEnglish
Published 25.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of treatment of diabetes, obesity, or an obesity associated disorder.
AbstractList The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of treatment of diabetes, obesity, or an obesity associated disorder.
Author Thomsen, Mikael S
Nielsen, Peter G
Højgaard, Bent
Author_xml – fullname: Højgaard, Bent
– fullname: Thomsen, Mikael S
– fullname: Nielsen, Peter G
BookMark eNrjYmDJy89L5WQwDUktzk9LzSvOzEtVSMxLUUhKLUlUSMrJT85OLVJIzs9NysxLLMnMz1NIyy_KLc0Bs4t5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8aLChkYGhmYWJgZORMTFqAJlbL4Q
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US12016840B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US12016840B23
IEDL.DBID EVB
IngestDate Fri Jul 19 10:38:44 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US12016840B23
Notes Application Number: US202217821905
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240625&DB=EPODOC&CC=US&NR=12016840B2
ParticipantIDs epo_espacenet_US12016840B2
PublicationCentury 2000
PublicationDate 20240625
PublicationDateYYYYMMDD 2024-06-25
PublicationDate_xml – month: 06
  year: 2024
  text: 20240625
  day: 25
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies SANIONA A/S
RelatedCompanies_xml – name: SANIONA A/S
Score 3.5536501
Snippet The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Tesofensine and beta blocker combination formulations
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240625&DB=EPODOC&locale=&CC=US&NR=12016840B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp6LzgwrSt-Jamy59KEK_GMI-cK3sbTQxgSm0Y63473sJnfNF30ICyeXgl99dcncBuBeFZzNJucWkZJZL-JsqeSvQkKN8UAhKCkclOI8n3ih3nxdk0YH3bS6MrhP6pYsjIqI44r3R5_V6d4kV69jK-oGtsKt6SrMgNlvvWNGTQ8w4DJLZNJ5GZhQF-dycvAQ2Ep2qaxLicb2HZjRV4X_Ja6iyUta_KSU9hv0ZzlY2J9ARZQ8Oo-3Paz04GLcP3thssVefAslEXUkVb14KA_1_g6GEBkMy-hAbA6VHH1dLbig7tP2Vqz6DuzTJopGF6y9_NrvM5ztRH8-hW1aluADDEwgW16fFgDKXE9-XCDYm5JBLZ-jZxSX0_56n_9_gFRwpxanwJ4dcQ7fZfIobJNqG3WoNfQNxeoOA
link.rule.ids 230,309,786,891,25585,76894
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7GFOebTkXnrwrSt-Jam659KEJ_UXXthmtlb6PpElChHWvFf99L6Zwv-hYSSK6BL99devcF4JZlhkq5mSuUc6roJF8KyVuGjpyZDzNmkkwTBc5RbISp_jQn8w68b2phGp3Qr0YcERGVI97r5rxebS-xvCa3srqjb9hVPgSJ7cltdCzoSSOy59j-dOJNXNl17XQmxy-2ikQndE0cPK530MW2hM6-_-qIqpTVb0oJDmB3irMV9SF0WNGHnrt5ea0Pe1H7wxubLfaqIyAJq0ou8s0LJmH8L1G0UKJIRh9sLaH1GOM2lkvCD21f5aqO4SbwEzdUcP3Fz8cu0tnW1PsT6BZlwU5BMhiCRbfMbGhSPSeWxRFslPFRzrWRoWZnMPh7nsF_g9fQC5NovBg_xs_nsC82UaRCaeQCuvX6k10i6db0qtmtb8dZhnM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Tesofensine+and+beta+blocker+combination+formulations&rft.inventor=H%C3%B8jgaard%2C+Bent&rft.inventor=Thomsen%2C+Mikael+S&rft.inventor=Nielsen%2C+Peter+G&rft.date=2024-06-25&rft.externalDBID=B2&rft.externalDocID=US12016840B2